Clinical Trial Update: A Phase II Trial to Evaluate the Efficacy and Safety of QL1706 in Patients With Cervical Cancer [Phase 2]

View source ↗

Summary

Phase II trial evaluating the efficacy and safety of QL1706 in patients with cervical cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cervical Cancer

Drugs mentioned

• QL1706

Snippet

Sponsor: Qilu Pharmaceutical Co., Ltd. | Conditions: Cervical Cancer | Phase 2 | Status: UNKNOWN